Mark Maurer
Foot & Ankle Surgery · Pueblo, CONPI 1891923033
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (32.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Arthrex at 54.2% of the total.
Across 83 payments — averaging $149.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$7K
- Stryker$4K
- Gemini Mountain Medical, LLC$521
- Treace Medical Concepts, Inc.$324
- Johnson & Johnson$149
- Smith+Nephew$143
- plus $373 from 9 others
What the payments were for
- Speaking & faculty fees$2,50020%
- Travel & lodging$3,29927%
- Food & beverage$2,52220%
- Education$3,96432%
- Gifts$951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 22 | $6,705 |
| Stryker(2 entities) | 32 | $4,167 |
| Gemini Mountain Medical, LLC | 2 | $521 |
| Treace Medical Concepts, Inc. | 3 | $324 |
| Johnson & Johnson | 3 | $149 |
| Smith+Nephew | 8 | $143 |
| Alliance Medical | 1 | $123 |
| Paragon 28, Inc. | 2 | $79 |
| Bioventus LLC | 2 | $39 |
| Acumed LLC | 2 | $31 |
| Amgen(2 entities) | 2 | $28 |
| Acell, Inc. | 1 | $23 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Abbott | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$2,125
- PROPHECY$608
- STAR$545
- PROstep$534
- INBONE$440
- TMC SPEEDMTP$149
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$107
How this compares
$12,381 in reported general payments places this provider in the 80th percentile of 181 foot & ankle surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 140 | $2,190 |
| Diclofenac Sodium | 65 | $1,741 |
| Gabapentin | 41 | $591 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $440 |
| Pregabalin | 18 | $248 |
| Doxycycline Hyclate | 12 | $143 |
| Meloxicam | 42 | $107 |
| Tramadol Hcl | 26 | $97 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Pueblo
- Stewart KitePueblo$8K
- Michael HoughtonFort Collins$2M
- Joshua MetzlEnglewood$1.8M
- Brad DresherColorado Springs$1.3M
- Thomas ClantonVail$1.1M
- Brett SachsWheat Ridge$806K
- Jeffrey LehrmanFort Collins$628K
- Kevin NagamaniDenver$288K
- Keith JacobsonDenver$241K
- William MontrossColorado Springs$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.